Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for the second quarter ended June 30, 2014. Onconova Therapeutics, Inc. (NASDAQ:ONTX) belongs to Healthcare sector. Its weekly performance is 5.50%. On last trading day company shares ended up $5.37. Onconova Therapeutics, Inc. (NASDAQ:ONTX) distance from 50-day simple … Continue reading Top Stories : Onconova Therapeutics (NASDAQ:ONTX), Comcast (NASDAQ:CMCSA), Salix Pharmaceuticals (NASDAQ:SLXP), Radio One Inc. (NASDAQ:ROIA), W&T Offshore (NYSE:WTI)